MedPath

The effects of Rituximab and Cyclosporine

Phase 1
Recruiting
Conditions
Steroid-resistant nephrotic syndrome.
Registration Number
IRCT20240614062128N1
Lead Sponsor
Ghoum University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
76
Inclusion Criteria

Resistant to Nephrotic Syndrome

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath